MAGENTA BLAST
Future Fertility, Inc. · Decision date Sep 18, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for MAGENTA BLAST, a traditional 510(k) submitted by Future Fertility, Inc. of Toronto, Canada, under number K261736. The decision date is 2026-09-18 and the application was received 05/27/2026. The device falls under classification name Embryo Image Assessment System, Assisted Reproduction, regulation number 884.6195, product code PBH, with the review panel and medical specialty listed as Obstetrics/Gynecology. SESE means the device was cleared as substantially equivalent to a predicate; it is not a PMA approval.
The public record lists a clinical trial identifier, NCT07464275, and states the submission was not reviewed by a third party, is not a combination product, and has no authorized predetermined change control plan. The specific components, software functions or changed items covered by the clearance are not described in the available source, and no summary statement is present, so the scope of what was cleared beyond the classification and product code remains unknown.
No clinical performance, efficacy or patient-selection conclusions are drawn here; those details would reside in the original FDA documents rather than this database entry.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Obstetrics/Gynecology
- Decision date
- Sep 18, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261736
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Future Fertility, Inc.
- Product code
- PBH
- Decision code
- SESE
- Decision date
- Sep 18, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Embryo Image Assessment System, Assisted Reproduction.
- Applicant
- Future Fertility, Inc.
- Product code
- PBH
- FDA device class
- 2
FDA decision timeline
K261736 received
Application receipt date recorded by FDA.
K261736 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Future Fertility, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Toronto
Sources and methodology
- Original FDA record: K261736
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records